Journal article
The prognostic significance of pretreatment serum lactate dehydrogenase in patients with small-cell lung cancer.
Abstract
Pretreatment serum lactate dehydrogenase (LDH) levels were assayed in 288 patients presenting with small-cell lung cancer (SCLC) between 1976 and 1985. Patients were routinely staged by physical examination, chest x-ray, bone, brain, and liver scans, and bone marrow evaluation. Clinical response and survival were assessed following treatment with combination chemotherapy as part of four clinical trials. Patients with extensive disease (ED) …
Authors
Sagman U; Feld R; Evans WK; Warr D; Shepherd FA; Payne D; Pringle J; Yeoh J; DeBoer G; Malkin A
Journal
Journal of Clinical Oncology, Vol. 9, No. 6, pp. 954–961
Publisher
American Society of Clinical Oncology (ASCO)
Publication Date
June 1991
DOI
10.1200/jco.1991.9.6.954
ISSN
0732-183X